Intrinsic Value of S&P & Nasdaq Contact Us

Recursion Pharmaceuticals, Inc. RXRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.00
+210.7%

Recursion Pharmaceuticals, Inc. (RXRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ABSI, AFMD, AVRO, CNSP, CWBR and others.

RXRX has a market capitalization of $1.58B, compared to an average peer market cap of $285.31M. RXRX is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message